Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
2020 · Cell · 563 citations
https://doi.org/10.1016/j.cell.2020.10.043
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
2.8K
Citations
19
h-index
19
i10-index
Samuel Wrenn is an academic researcher. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & SARS-CoV-2 detection and testing. The author has an h-index of 19, co-authored 20 publications.
https://doi.org/10.1016/j.cell.2020.10.043
https://doi.org/10.1016/j.immuni.2023.08.011
https://doi.org/10.21203/rs.3.rs-57112/v1
https://doi.org/10.1016/j.jim.2021.113160
Click to start Chat